Published in Br J Clin Pharmacol on April 01, 1975
Energy drinks mixed with alcohol: misconceptions, myths, and facts. Int J Gen Med (2012) 1.37
Single-dose effects of tranylcypromine on psychophysiological measures in normals. Br J Clin Pharmacol (1978) 0.82
Effects of alcohol mixed with energy drink and alcohol alone on subjective intoxication. Amino Acids (2013) 0.81
Brain transmitter precursors and metabolites in diabetic ketoacidosis. J Neurol Neurosurg Psychiatry (1982) 0.78
Milk Collected at Night Induces Sedative and Anxiolytic-Like Effects and Augments Pentobarbital-Induced Sleeping Behavior in Mice. J Med Food (2015) 0.76
A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest (1956) 20.76
Residual effects of hypnotics. Psychopharmacologia (1972) 3.43
Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J Neurochem (1971) 3.34
The determination of tryptophan in plasma, liver, and urine. J Lab Clin Med (1967) 3.10
Peripheral beta-adrenergic receptors concerned with tremor. Clin Sci (1967) 2.97
The action of sedatives on brain stem oculomotor systems in man. Neuropharmacology (1971) 2.39
Reliability, validity, and clinical application of the Visual Analogue Mood Scale. Psychol Med (1973) 2.31
The specific binding of L-tryptophan to serum albumin. J Biol Chem (1958) 2.20
Free tryptophan in plasma and brain tryptophan metabolism. Nature (1972) 1.91
Plasma serotonin in migraine and stress. Arch Neurol (1967) 1.53
Central and peripheral effects of propranolol and sotalol in normal human subjects. Br J Pharmacol (1972) 1.48
Serum tryptophan level after carbohydrate ingestion: selective decline in non-albumin-bound tryptophan coincident with reduction in serum free fatty acids. Life Sci II (1973) 1.38
Sequential comparison of L-tryptophan with E.C.T. in severe depression. Lancet (1970) 1.38
Physiologic and clinical effects of chlorpromazine and their relationship to plasma level. Clin Pharmacol Ther (1973) 1.36
5-hydroxyindole metabolism in rat brain. A study of intermediate metabolism using the technique of tryptophan loading. II. Applications and drug studies. J Neurochem (1965) 1.27
POTENTIATION OF MONOAMINE-OXIDASE INHIBITORS BY TRYPTOPHAN. Lancet (1963) 1.21
Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan. Lancet (1963) 1.16
Response of free fatty acids to coffee and caffeine. Metabolism (1968) 1.12
Comparative trial of L-tryptophan and E.C.T. in severe depressive illness. Lancet (1974) 1.11
Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor. Neurology (1960) 1.08
Central-nervous-system effects of ingestin of L-tryptophan by normal subjects. N Engl J Med (1962) 1.02
Effects of amino acid feedings in schizophrenic patients treated with iproniazid. Science (1961) 1.00
Tryptophan in the treatment of depression. Lancet (1967) 1.00
Some experiments in the chemistry of normal sleep. Br J Psychiatry (1966) 0.99
Effects of L-tryptophan (a natural sedative) on human sleep. Lancet (1970) 0.97
The comparative antidepressant value of L-tryptophan and imipramine with and without attempted potentiation by liothyronine. Arch Gen Psychiatry (1972) 0.96
The acute effects of intravenous infusion of L-tryptophan in normal subjects. Clin Pharmacol Ther (1974) 0.95
Observations of schizophrenic patients after iproniazid and tryptophan. AMA Arch Neurol Psychiatry (1958) 0.93
Potentiation of a monoamine oxidase inhibitor by tryptophan. J Psychiatr Res (1969) 0.87
REDUCTION OF THE CENTRAL EFFECTS OF TRYPTOPHAN BY A DECARBOXYLASE INHIBITOR. Clin Pharmacol Ther (1964) 0.83
Tryptophan and sleep. Lancet (1972) 0.80
L-METHIONINE AND L-TRYPTOPHAN FEEDINGS IN NON-PSYCHOTIC AND SCHIZOPHRENIC PATIENTS WITH AND WITHOUT TRANYLCYPROMINE. J Nerv Ment Dis (1963) 0.78
Tolerance and dependence to serotonin. A speculation. Arch Gen Psychiatry (1973) 0.78
Repetitive auditory stimuli and the development of sleep. Electroencephalogr Clin Neurophysiol (1966) 0.77
Tryptophan and sleep in young adults. Psychophysiology (1972) 0.77
5-hydroxyindoles and migraine. Adv Pharmacol (1968) 0.77
Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain. Br J Pharmacol (1970) 4.48
Withdrawal from long-term benzodiazepine treatment. Br Med J (Clin Res Ed) (1981) 3.83
Residual effects of hypnotics. Psychopharmacologia (1972) 3.43
The residual effects of flurazepam. Psychopharmacologia (1973) 2.93
Residual effects of flunitrazepam. Br J Clin Pharmacol (1975) 2.56
Response to propranolol and diazepam in somatic and psychic anxiety. Br Med J (1974) 2.23
Tryptophan pyrrolase--a biochemical factor in depressive illness? Br J Psychiatry (1969) 1.98
Effects of immobilization and food deprivation on rat brain tryptophan metabolism. J Neurochem (1972) 1.96
Free tryptophan in plasma and brain tryptophan metabolism. Nature (1972) 1.91
Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet (1979) 1.72
Decrease of 5-hydroxytryptamine in the brain provoked by hydrocortisone and its prevention by allopurinol. Nature (1968) 1.69
Effects on plasma and brain tryptophan in the rat of drugs and hormones that influence the concentration of unesterified fatty acid in the plasma. Br J Pharmacol (1974) 1.68
Clinical management of benzodiazepine dependence. Br Med J (Clin Res Ed) (1985) 1.68
Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP). Acta Psychiatr Scand (2010) 1.67
The occurrence of Listeria monocytogenes in cheese from a manufacturer associated with a case of listeriosis. Int J Food Microbiol (1990) 1.53
Benzodiazepine dependence. Br J Addict (1981) 1.50
Central and peripheral effects of propranolol and sotalol in normal human subjects. Br J Pharmacol (1972) 1.48
The microbiology of selected retail food products with an evaluation of viable counting methods. J Hyg (Lond) (1984) 1.46
Computed axial brain tomography in long-term benzodiazepine users. Psychol Med (1984) 1.46
The contribution of tryptamine to the behavioural effects of l-Tryptophan in tranylcypromine-treated rats. Psychopharmacology (Berl) (1978) 1.45
The effect of tryptophan metabolites on brain 5-hydroxytryptamine metabolism. Biochem Pharmacol (1970) 1.41
Physiological and psychological measures in anxious patients. Psychol Med (1974) 1.41
Plasma concentrations of benzodiazepines. Br J Clin Pharmacol (1977) 1.41
Physiologic and clinical effects of chlorpromazine and their relationship to plasma level. Clin Pharmacol Ther (1973) 1.36
Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors. Psychopharmacology (Berl) (1988) 1.35
Comparative trial of L-tryptophan and amitriptyline in depressive illness. Psychol Med (1976) 1.32
The effect of fatty acids on the binding of tryptophan to plasma protein. Nature (1973) 1.30
Microbial ecology of Campylobacter jejuni in a United Kingdom chicken supply chain: intermittent common source, vertical transmission, and amplification by flock propagation. Appl Environ Microbiol (1996) 1.29
Letter: Factors influencing effect of hydrocortisone on rat brain tryptophan metabolism. Nature (1975) 1.27
Sedative effects on physiological and psychological measures in anxious patients. Psychol Med (1974) 1.25
Effects of p-chlorophenylalanine and alpha-methyltryptophan on behaviour and brain 5-hydroxyindoles. Neuropharmacology (1977) 1.24
Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest (1976) 1.23
Palmar skin conductance measures in anxiety and phobic states. J Psychosom Res (1967) 1.21
Effects of beta adrenergic blockade with sotalol in chronic anxiety. Clin Pharmacol Ther (1973) 1.18
Effects of chronic porto-caval anastomosis on brain tryptophan, tyrosine and 5-hydroxytryptamine. J Neurochem (1975) 1.14
Drug-induced extrapyramidal syndromes. J R Coll Physicians Lond (1970) 1.12
5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat. Br J Pharmacol (1978) 1.11
Metabolism of an oral tryptophan load. I: Effects of dose and pretreatment with tryptophan. Br J Clin Pharmacol (1980) 1.11
The oxidation of NN-dimethyl-p-phenylenediamine by oxidizing agents and by caeruloplasmin. Biochem J (1967) 1.11
Chocolate bars contaminated with Salmonella napoli: an infectivity study. Br Med J (Clin Res Ed) (1983) 1.09
Self-report reliability and symptomatology of habitual caffeine consumption. Br J Clin Pharmacol (1989) 1.08
Withdrawal reaction from clobazam. Br Med J (Clin Res Ed) (1981) 1.08
The inheritance of neurotic traits: a twin study of the Middlesex Hospital Questionnaire. Br J Psychiatry (1971) 1.08
Continuous source outbreak of campylobacteriosis traced to chicken. J Food Prot (2000) 1.07
A controlled comparison of flupenthixol and amitriptyline in depressed outpatients. Br Med J (1976) 1.06
Dopamine and serotonin metabolism in hepatic encephalopathy. Br Med J (1974) 1.06
The inhibition of caeruloplasmin by azide. Biochem J (1966) 1.06
Hangover effect of hypnotics in man. Nature (1971) 1.06
Treatment of Parkinson's disease with amantadine and levodopa. A one-year study. Lancet (1971) 1.06
Electromyographic studies of tremor using an averaging computer. Electroencephalogr Clin Neurophysiol (1969) 1.06
Relationships between plasma, CSF and brain tryptophan. J Neural Transm Suppl (1979) 1.05
Studies on the behavioural effects of tryptophan and rho-chlorophenylalanine. Neuropharmacology (1976) 1.05
Monitoring the effect of a tryptophan load on brain indole metabolism in freely moving rats by simultaneous cerebrospinal fluid sampling and brain dialysis. J Neurochem (1985) 1.05
Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology (Berl) (1985) 1.03
Plasma and brain tryptophan changes in experimental acute hepatic failure. J Neurochem (1973) 1.03
Amine metabolites in the cerbrospinal fluid in Huntington's chorea. J Neurol Neurosurg Psychiatry (1972) 1.03
Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Br J Pharmacol (1988) 1.02
Benzodiazepine derivatives--side effects and dangers. Biol Psychiatry (1981) 1.02
Bodily reactions to people and events in schizophrenics. Arch Gen Psychiatry (1979) 1.01
Female rats are more vulnerable than males in an animal model of depression: the possible role of serotonin. Brain Res (1986) 1.01
Amine metabolites in the lumbar cerebrospinal fluid of humans with restricted flow of cerebrospinal fluid. Nat New Biol (1971) 1.00
Comparative effects of diazepam and buspirone on subjective feelings, psychological tests and the EEG. Int Pharmacopsychiatry (1981) 1.00
Psychometric performance during withdrawal from long-term benzodiazepine treatment. Psychopharmacology (Berl) (1983) 0.99
Interactions between sympathomimetic amines and a new monoamine oxidase inhibitor. Psychopharmacologia (1970) 0.99
Effects of immobilization on rat liver tryptophan pyrrolase and brain 5-hydroxytryptamine metabolism. Br J Pharmacol (1969) 0.99
Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. Eur J Pharmacol (1989) 0.97
The effect of adrenaline on human platelet MAO activity. Psychopharmacologia (1975) 0.96
Control of brain tryptophan concentration in rats on a high fat diet. Nature (1976) 0.96
Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression. Eur J Pharmacol (1987) 0.96
Urinary monoamine oxidase inhibitor and benzodiazepine withdrawal. Br J Psychiatry (1982) 0.96
Neuroleptics and abnormal movements. Br Med J (Clin Res Ed) (1982) 0.96
Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis. Neurosci Lett (1989) 0.96
Involuntary movements other than Parkinsonism: biochemical aspects. Proc R Soc Med (1973) 0.96
Is nicotine important to tobacco smoking? Clin Pharmacol Ther (1977) 0.96
Narcolepsy and cataplexy. Clinical features, treatment and cerebrospinal fluid findings. Q J Med (1974) 0.95
The acute effects of intravenous infusion of L-tryptophan in normal subjects. Clin Pharmacol Ther (1974) 0.95
The metabolism of a tryptophan load in rat brain and liver. The influence of hydrocortisone and allopurinol. Biochem Pharmacol (1976) 0.95
Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine. Psychopharmacology (Berl) (1998) 0.95
A method for the determination of dopa and 3-O-methyldopa in the plasma of Parkinsonian patients. Clin Chim Acta (1972) 0.95
Comparative psychotropic effects of metoclopramide and prochlorperazine in normal subjects. J Clin Pharmacol (1975) 0.95
Effects of albumin, amino acids, and clofibrate on the uptake of tryptophan by the rat brain. J Neurochem (1980) 0.95
Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Eur J Pharmacol (1987) 0.94
Inhibitors of caeruloplasmin. Biochem J (1967) 0.94
Enhancement of some 5-HT-dependent behavioural responses following repeated immobilization in rats. Brain Res (1985) 0.94
Parkinson's disease, cerebral arteriosclerosis, and senile dementia. Clinical features and response to levodopa. Q J Med (1974) 0.93
Effect of increased rat brain tryptophan on 5-hydroxytryptamine and 5-hydroxyindolyl acetic acid in the hypothalamus and other brain regions. J Neurochem (1974) 0.93
5-HT1B agonists induce anorexia at a postsynaptic site. Eur J Pharmacol (1987) 0.93
The role of tryptamine in the behavioural effects of tranylcypromine + L-tryptophan. Neuropharmacology (1979) 0.93
The relevance of both plasma free tryptophan and insulin to rat brain tryptophan concentration. J Neurochem (1976) 0.93
Hypothermia induced by the putative 5-HT1A agonists LY165163 and 8-OH-DPAT is not prevented by 5-HT depletion. Eur J Pharmacol (1987) 0.93
Metabolism of an oral tryptophan load. II: Effect of pretreatment with the putative tryptophan pyrrolase inhibitors nicotinamide or allopurinol. Br J Clin Pharmacol (1980) 0.92
Acute and chronic effects of lithium chloride on physiological and psychological measures in normals. Psychopharmacology (Berl) (1978) 0.92
Modification of the standard method used in the United Kingdom for counting Escherichia coli in live bivalve molluscs. Commun Dis Public Health (1998) 0.92
A controlled comparison of fluoxetine and amitriptyline in depressed out-patients. Br J Psychiatry (1987) 0.92
The biochemistry of dyskinesias. Int Rev Neurobiol (1967) 0.92
Clinical comparison of anxiolytic drug therapy. Psychol Med (1974) 0.91
A study of proposed determinants of brain tryptophan concentration in rats after portocaval anastomosis or sham operation. J Neurochem (1978) 0.91